Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 10

1.

Meta-analysis of risk reduction estimates associated with risk-reducing salpingo-oophorectomy in BRCA1 or BRCA2 mutation carriers.

Rebbeck TR, Kauff ND, Domchek SM.

J Natl Cancer Inst. 2009 Jan 21;101(2):80-7. doi: 10.1093/jnci/djn442.

2.

Serous tubal intraepithelial carcinoma: its potential role in primary peritoneal serous carcinoma and serous cancer prevention.

Carlson JW, Miron A, Jarboe EA, Parast MM, Hirsch MS, Lee Y, Muto MG, Kindelberger D, Crum CP.

J Clin Oncol. 2008 Sep 1;26(25):4160-5. doi: 10.1200/JCO.2008.16.4814.

3.

A prospective study of risk-reducing salpingo-oophorectomy and longitudinal CA-125 screening among women at increased genetic risk of ovarian cancer: design and baseline characteristics: a Gynecologic Oncology Group study.

Greene MH, Piedmonte M, Alberts D, Gail M, Hensley M, Miner Z, Mai PL, Loud J, Rodriguez G, Basil J, Boggess J, Schwartz PE, Kelley JL, Wakeley KE, Minasian L, Skates S.

Cancer Epidemiol Biomarkers Prev. 2008 Mar;17(3):594-604. doi: 10.1158/1055-9965.EPI-07-2703.

5.

Perceived ambiguity about screening mammography recommendations: association with future mammography uptake and perceptions.

Han PK, Kobrin SC, Klein WM, Davis WW, Stefanek M, Taplin SH.

Cancer Epidemiol Biomarkers Prev. 2007 Mar;16(3):458-66.

6.

Mortality after bilateral salpingo-oophorectomy in BRCA1 and BRCA2 mutation carriers: a prospective cohort study.

Domchek SM, Friebel TM, Neuhausen SL, Wagner T, Evans G, Isaacs C, Garber JE, Daly MB, Eeles R, Matloff E, Tomlinson GE, Van't Veer L, Lynch HT, Olopade OI, Weber BL, Rebbeck TR.

Lancet Oncol. 2006 Mar;7(3):223-9.

PMID:
16510331
7.

Prophylactic oophorectomy reduces breast cancer penetrance during prospective, long-term follow-up of BRCA1 mutation carriers.

Kramer JL, Velazquez IA, Chen BE, Rosenberg PS, Struewing JP, Greene MH.

J Clin Oncol. 2005 Dec 1;23(34):8629-35.

PMID:
16314625
8.

Fallopian tube and primary peritoneal carcinomas associated with BRCA mutations.

Levine DA, Argenta PA, Yee CJ, Marshall DS, Olvera N, Bogomolniy F, Rahaman JA, Robson ME, Offit K, Barakat RR, Soslow RA, Boyd J.

J Clin Oncol. 2003 Nov 15;21(22):4222-7. Review.

PMID:
14615451
9.

Histopathologic features of ovaries at increased risk for carcinoma. A case-control analysis.

Sherman ME, Lee JS, Burks RT, Struewing JP, Kurman RJ, Hartge P.

Int J Gynecol Pathol. 1999 Apr;18(2):151-7.

PMID:
10202673
10.

Intra-abdominal carcinomatosis after prophylactic oophorectomy in ovarian-cancer-prone families.

Tobacman JK, Greene MH, Tucker MA, Costa J, Kase R, Fraumeni JF Jr.

Lancet. 1982 Oct 9;2(8302):795-7.

PMID:
6126666
Items per page

Supplemental Content

Support Center